142 related articles for article (PubMed ID: 34493460)
21. Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling.
van der Leest P; Ketelaar EM; van Noesel CJM; van den Broek D; van Boerdonk RAA; Deiman B; Rifaela N; van der Geize R; Huijsmans CJJ; Speel EJM; Geerlings MJ; van Schaik RHN; Jansen MPHM; Dane-Vogelaar R; Driehuis E; Leers MPG; Sidorenkov G; Tamminga M; van Kempen LC; Schuuring E
Clin Chem; 2022 Jul; 68(7):963-972. PubMed ID: 35616097
[TBL] [Abstract][Full Text] [Related]
22. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
23. Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing.
Hellwig S; Nix DA; Gligorich KM; O'Shea JM; Thomas A; Fuertes CL; Bhetariya PJ; Marth GT; Bronner MP; Underhill HR
PLoS One; 2018; 13(7):e0197333. PubMed ID: 30044795
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma.
Warton K; Yuwono NL; Cowley MJ; McCabe MJ; So A; Ford CE
Mol Diagn Ther; 2017 Oct; 21(5):563-570. PubMed ID: 28631163
[TBL] [Abstract][Full Text] [Related]
25. Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.
Till JE; Black TA; Gentile C; Abdalla A; Wang Z; Sangha HK; Roth JJ; Sussman R; Yee SS; O'Hara MH; Thompson JC; Aggarwal C; Hwang WT; Elenitoba-Johnson KSJ; Carpenter EL
J Mol Diagn; 2021 Nov; 23(11):1545-1552. PubMed ID: 34454115
[TBL] [Abstract][Full Text] [Related]
26. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial Fraction of Circulating Cell-Free DNA as an Indicator of Human Pathology.
Panagopoulou M; Karaglani M; Tzitzikou K; Kessari N; Arvanitidis K; Amarantidis K; Drosos GI; Gerou S; Papanas N; Papazoglou D; Baritaki S; Constantinidis TC; Chatzaki E
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673785
[TBL] [Abstract][Full Text] [Related]
28. A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA.
Ottaviano M; Giuliano M; Tortora M; La Civita E; Liotti A; Longo M; Bruzzese D; Cennamo M; Riccio V; De Placido P; Picozzi F; Parola S; Daniele B; Botti G; Formisano P; Beguinot F; De Placido S; Terracciano D; Palmieri G
Front Oncol; 2020; 10():602153. PubMed ID: 33634024
[TBL] [Abstract][Full Text] [Related]
29. Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells.
Takeda K; Yamada T; Takahashi G; Iwai T; Ueda K; Kuriyama S; Koizumi M; Matsuda A; Shinji S; Ohta R; Yokoyama Y; Hotta M; Hara K; Yoshida H
Cancer Sci; 2019 Nov; 110(11):3497-3509. PubMed ID: 31465598
[TBL] [Abstract][Full Text] [Related]
30. Isolation of Cell-Free DNA from Maternal Plasma.
Stray J; Zimmermann B
Methods Mol Biol; 2019; 1885():309-323. PubMed ID: 30506207
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.
Li M; Jia Y; Xu J; Cheng X; Xu C
Ann Hematol; 2017 Aug; 96(8):1343-1351. PubMed ID: 28623396
[TBL] [Abstract][Full Text] [Related]
32. Progress in quantitative technique of circulating cell free DNA and its role in cancer diagnosis and prognosis.
Weng JL; Atyah M; Zhou CH; Ren N
Cancer Genet; 2019 Nov; 239():75-84. PubMed ID: 31639530
[TBL] [Abstract][Full Text] [Related]
33. Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence.
Pasternack H; Fassunke J; Plum PS; Chon SH; Hescheler DA; Gassa A; Merkelbach-Bruse S; Bruns CJ; Perner S; Hallek M; Büttner R; Bollschweiler E; Hölscher AH; Quaas A; Zander T; Weiss J; Alakus H
Sci Rep; 2018 Oct; 8(1):14941. PubMed ID: 30297788
[TBL] [Abstract][Full Text] [Related]
34. Comparison of 4 commercial kits for the extraction of circulating DNA from plasma.
Warton K; Graham LJ; Yuwono N; Samimi G
Cancer Genet; 2018 Dec; 228-229():143-150. PubMed ID: 29567030
[TBL] [Abstract][Full Text] [Related]
35. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.
Vietsch EE; Graham GT; McCutcheon JN; Javaid A; Giaccone G; Marshall JL; Wellstein A
Cancer Genet; 2017 Dec; 218-219():39-50. PubMed ID: 29153095
[TBL] [Abstract][Full Text] [Related]
36. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
Pérez-Barrios C; Nieto-Alcolado I; Torrente M; Jiménez-Sánchez C; Calvo V; Gutierrez-Sanz L; Palka M; Donoso-Navarro E; Provencio M; Romero A
Transl Lung Cancer Res; 2016 Dec; 5(6):665-672. PubMed ID: 28149760
[TBL] [Abstract][Full Text] [Related]
37. Investigating the Z-scan technique for quantifying circulating cell-free DNA (ccfDNA) extracted from blood plasma as a potential biomarker for various cancers.
Ara H; Tarek SA; Biswas MK; Al-Din SMS; Hoque E; Hasan KME; Hossain AKMM; Faruque SB; Haque Y; Sharafuddin SM
Biomed Phys Eng Express; 2024 May; 10(4):. PubMed ID: 38718773
[TBL] [Abstract][Full Text] [Related]
38. Interlaboratory evaluation of quality control methods for circulating cell-free DNA extraction.
Devonshire A; Jones G; Gonzalez AF; Kofanova O; Trouet J; Pinzani P; Gelmini S; Bonin S; Foy C
N Biotechnol; 2023 Dec; 78():13-21. PubMed ID: 37730172
[TBL] [Abstract][Full Text] [Related]
39. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.
Lippert J; Smith G; Appenzeller S; Landwehr LS; Prete A; Steinhauer S; Asia M; Urlaub H; Elhassan YS; Kircher S; Arlt W; Fassnacht M; Altieri B; Ronchi CL
Eur J Endocrinol; 2024 Mar; 190(3):234-247. PubMed ID: 38451242
[TBL] [Abstract][Full Text] [Related]
40. Involvement of Circulating Cell-Free Mitochondrial DNA and Proinflammatory Cytokines in Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer.
Bulgakova O; Kausbekova A; Kussainova A; Kalibekov N; Serikbaiuly D; Bersimbaev R
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1927-1933. PubMed ID: 34181353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
